Genome-directed treatment targets and mutational signature biomarkers: a retrospective, pan-solid tumour analysis.
Research paper from Europe PMC. Evidence status: source reported.
- Published
- 2026-11-16
- Source reference
- MED:43039016
- DOI
- 10.1016/s1470-2045(26)00406-7
- Jurisdiction
- Not assessed
- Licence
- Bibliographic metadata only; article rights retained
Black D, Davies HR, DeVerinne C, Cubric M, Chalivelaki Chan G, Czarnecki J, Rinaldi G, Zhao SJ, Degasperi A, Marciniak S, Rintoul RC, McCaughan F, Middleton G, Nik-Zainal S. · Lancet Oncol · im; journal article · Found via: Genomics England
Source: https://europepmc.org/article/MED/43039016. Captured 2026-11-18.
Limitations: Discovered through a Europe PMC keyword search for Genomics England. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.